Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round

Corporate Breaking News

Home : Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round

Jun 10 2021	Actimed Therapeutics Announces Successful Closing of £2.5m Extended Seed B Funding Round
LONDON, June 10, 2021 /PRNewswire/ -- Actimed Therapeutics Ltd, the clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, with a focus on cachexia, today announces the successful closing of its extended Seed B financing round which was...


Source:https://www.prnewswire.com:443/news-releases/actimed-therapeutics-announces-successful-closing-of-2-5m-extended-seed-b-funding-round-301309203.html

Related News
» PUBLICACIÓN EMBARGADA: Reino Unido y Europa occidental tienen empleados menos comprometidos » Fosun Fashion Group to Acquire Italian Luxury Shoemaker Sergio Rossi